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A library of selective antagonists of the FK506-binding protein 51
The FK506-binding protein 51 (FKBP51) is intimately involved
in the regulation of glucocorticoid stress receptors, and its up-reg-
ulation has been associated with depression-like illnesses. How-
ever, the search for novel ligands for this protein have been
complicated by the need for high selectivity over the struc-
turally-related protein FKBP52. The key active sites of both pro-
teins are highly conserved, and historically, it has proven difﬁcult
to identify ligands that can discriminate between the two targets.
A recent publication has used the solid-phase synthesis of pipecolic
dipeptides to reveal compounds with high afﬁnity and selectivity
for FKBP51 [1].
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Two FKBP51-selective antagonists (SAFit1and SAFit2; 1 and 2)
for FKBP51 have previously been discovered. These tool com-
pounds permitted conﬁrmation of the hypothesis that FKBP51
inhibition enhances stress hormone regulation and have anti-
depressant-like activity. However, these two compounds do not
have physical properties consistent with CNS-penetration, andhttp://dx.doi.org/10.1016/j.comche.2016.03.002
E-mail: nterrett@ensembletx.comthus the recent study intended to ﬁnd lead compounds more
suitable for therapeutic use.
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Reducing the size of the SAFit ligands and removing the
vulnerable ester group resulted in the FKBP51-selective and potent
inhibitor compound 3. Signiﬁcant reduction of the amide
substituent size resulted in some loss of inhibitory activity, but
provided a good starting point for further structural investigation.
Using an efﬁcient solid-phase assisted synthesis method a library
of 37 compounds (4) was prepared in which there was
considerable variation of the amide substituent. Cleavage of
the ﬁnal products from the solid support provided the pipecolic
acid derivative in 20–90% overall chemical yield and >90% purity.
Of all the analogues synthesised, the cyclopentyl derivative 5
demonstrated the highest afﬁnity with a Ki value of 0.1 lM. A
co-crystal structure of the compound bound to FKBP51 was
solved revealing its interactions with the protein. Compound 5
has a greater polar surface area than SAFit2, suggesting that further
optimisation is required to achieve the necessary CNS penetration.
However, the compound provides an improved starting point for
the further development of FKBP51-targeted compounds.
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CONH2A summary of the papers in this month’s issue
Polymer supported synthesis
No papers this month.
Solution-phase synthesis
An effective oxidative intramolecular cyclization (C–S bond
formation) of thiosemicarbazones using 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (DDQ) has been developed to afford a diverse
array of 2-amino-substituted-1,3,4-thiadiazoles. The attractive
features of this protocol are operational simplicity, no need for
expensive transition-metal catalysts and broad substrate scope [2].
Scaffolds and synthons for combinatorial libraries
Six sets of functionalised building blocks based on 5,6,7,8-
tetrahydro[1,2,4]triazolo[4,3-a]pyridine as well as 5,6,7,8-tetrahy-
dro[1,2,4]triazolo[1,5-a]pyridine cores have been prepared. These
compounds are non-ﬂat, bicyclic heterocycles that are likely to ﬁnd
utility as privileged motifs for lead-like compound design. One set
of building blocks, (5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-
6-ylmethyl)amines, proved useful as a scaffold for developing com-
pounds that stimulate glucagon-like peptide-1 (GLP-1) secretion
and are novel anti-diabetes drug leads [3].
Dermatan sulfate (DS) is composed of a repeating disaccharide
unit containing iduronic acid (IdoA) and N-acetylgalactosamine
(GalNAc). In the divergent synthesis of DS disaccharide, it is neces-
sary to prepare the IdoA moiety with a diverse set of protecting
groups. IdoA has been efﬁciently obtained from glucose in 20 steps
with some modiﬁcations following a previously reported method.
The disaccharide building block has been used in the synthesis of
DS-B disaccharide and its ligand conjugate [4].
There are over one thousand natural products that contain the
octahydroindole scaffold, which can be considered a biologically
validated starting point for the design of compound libraries. A
recent paper describes the synthesis of two chiral octahydroindole
scaffolds in multigram quantities in two steps from a readily avail-
able indoline. They contain either one or two amino groups (oneBoc-protected) and a protected carboxylic acid group, and have
been designed for ease of conversion to a lead generation library.
The structures of both scaffolds have been established unequivo-
cally by single crystal X-ray structure determination [5].
Solid-phase supported reagents
Substituted amines have been obtained under mild conditions
and in good yields using the Aza-Michael-type addition of various
amines to vinyl compounds catalysed by a supported ionic liquid
incorporating an anionic heteropoly acid. Different catalysts,
including Lewis acids, Brønsted acids and heteropoly acids have
been investigated in which heteropoly acids having dual Brønsted
and Lewis acid characteristics were found to be excellent catalysts.
In particular, the ionic liquid incorporating a polytungstate anion
supported on magnetic diatomaceous earth as a magnetically
separable heterogeneous catalyst offered the best results in terms
of yield [6].
An efﬁcient, one-pot, three-component protocol for the
synthesis of a small library of chiral isoxazolidines and spiroisoxa-
zolidines with high diastereoselectivity, from the reaction of
N-arylhydroxylamines, arylaldehydes, isatins, and a,b-unsaturated
aldehydes has been described. Using L-proline functionalised Fe3O4
nanoparticles as a magnetic organocatalyst gave isoxazolidine
products in high yields as single isomers with an endo-conﬁgura-
tion. Notable features of this methodology were short reaction
time, good to excellent yields, and use of an easily recovered
heterogeneous catalyst that could be reused many times without
signiﬁcant loss of its catalytic activity [7].
An efﬁcient and environmentally benign protocol for the
synthesis of a new class of diversely functionalised novel 1H-
indol-3-yl-4H-chromene-3-carbonitriles has been described using
a one-pot three-component condensation reaction of 3-(1H-
indol-3-yl)-3-oxopropanenitrile, 5,5-dimethylcyclohexane-1,3-dione,
and various aldehydes in the presence of polystyrene-supported
p-toluenesulfonic acid (PS/PTSA) under solvent-free conditions. This
methodology offers several advantages such as short reaction time,
simple operational procedure, avoids toxic solvent, generates high
yield of product and endures the substrate diversity. The PS/PTSA
catalyst is readily available in stable form which is fairly inexpensive
and can be easily recovered from the reaction medium without
appreciable changes for further reuse [8].
Novel resins, linkers and techniques
No papers this month.
Library applications
The inhibition of acetylcholinesterase has been shown to be
improved by transforming the hydroxyl group on the main ring
of a model hydroxypyridinone compound into an N,N-dimethylcar-
bamate group. The development of second generation libraries
based on this learning has recently been reported. Candidates that
adhere to drug-like criteria from a virtual library of compounds
were tested using computational docking studies. Consequently,
synthesis and characterisation of chosen test compounds and their
acetylcholinesterase inhibitory activity have been presented [9].
A novel analysis method consisting of size-exclusion chro-
matography and HRMS analysis was ﬁrst applied to the discovery
of potential inhibitors of cancer drug targets. Employing vascular
endothelial growth factor receptor (VEGFR-2) as a target, dynamic
combinatorial libraries have been prepared by reacting aldehydes
with amines. Four sensitive binders that targeted VEGFR-2 were
directly isolated from the library, and antitumour activity in vitro
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performed [10].
Sunitinib is a receptor tyrosine kinase (RTK) and angiogenesis
inhibitor approved for the treatment of renal cell carcinomas, gas-
trointestinal stromal tumours and pancreatic neuroendocrine
tumours. A key structural motif was believed to be the indoline-
2-one group, but in the search for new anti-angiogenic scaffolds
it has been reported that non-indoline-2-one-based derivatives
are also active, indicating that the group is not essential for
activity. The synthesis and structure–activity relationships of
non-indoline-2-one angiogenesis inhibitors related to sunitinib
based on 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones have been
described. A focussed library of 19 analogues has been prepared
using a simple novel process, and screening of the library using a
cell-based endothelial tube formation assay identiﬁed six com-
pounds with anti-angiogenesis activity [11].
The initial attachment of inﬂuenza virus to cells is the binding
of hemagglutinin (HA) to the sialyloligosaccharide receptor. There-
fore, small molecules that inhibit the sugar–protein interaction
could be promising as HA inhibitors that prevent infection. Sialic
acid-mimic heptapeptides have recently been identiﬁed through
selection from a primary library against inﬂuenza virus HA. Alanine
scanning of the peptides indicated that arginine and proline were
responsible for binding, and the afﬁnities against H3 HA of several
mutant peptides with single-amino-acid substitutions were
determined. These results provide a practicable method to design
peptide-based HA inhibitors that are promising anti-inﬂuenza
drugs [12].
A library of nitric oxide-donor doxorubicins (NO–DOXOs) has
been synthesised by linking appropriate NO-donor moieties at
the C-14 position through an ester bridge. Their hydrolytic stability
was evaluated, and the intracellular accumulation and cytotoxicity
of these novel NO–DOXOs have been studied in DOXO-sensitive
(HT29) and DOXO-resistant (HT29/dx) tumour-cells [13].
Small-molecule ﬂuorescent reporters of disease states are
highly sought after, yet they remain elusive. The optical properties
of a small library of N-isopropyl invariant anthranilic acids have
been investigated in both methanol and chloroform. A number of
substituents were explored and in particular, the boron-containing
anthranilic acids were evaluated as sensitive ﬂuorescent probes for
cancer cells using laser scanning confocal microscopy. In general,
the compounds produced blue ﬂuorescence that was strongly
inﬂuenced by substitution and environment. It was demonstrated
that phenylboronic acid conjugation was an attractive method
for cancer cell detection via boronate ester formation with
overexpressed glycoproteins presumably due to favourable
boron-sialic acid interactions [14].
Small libraries of N-substituted saccharin and N-/O-substituted
acesulfame derivatives have been synthesised and tested as
atypical and selective inhibitors of four different isoforms of
human carbonic anhydrase (hCA I, II, IX and XII, EC 4.2.1.1). Most
of them inhibited hCA XII in the low nanomolar range, hCA IX with
Kis ranging between 19 and 2482 nM, although they were poorly
active against hCA II (Kis > 10 lM) and hCA I (Kis ranging between
318 nM and 50 lM). Since hCA I and II are ubiquitous off-target
isoforms, whereas the cancer-related isoforms hCA IX and XII were
recently validated as drug targets, these results represent an
encouraging achievement in the development of new anticancer
candidates. Moreover, the lack of a classical zinc binding
group in the structure of these inhibitors opens innovative, yet
unexplored scenarios for different mechanisms of inhibition [15].
Synthesis of a focussed library of trans-stilbene compounds
through Wittig and other base-catalysed condensation reactions
has been presented. The synthesised stilbenes were screened for
their inhibitory potential against murine tyrosinase activity to
explore structure activity relationships. One compound ((E)-2,3-bis(4-hydroxyphenyl)acryonitrile) was found to be the most
active with an IC50 value of 5.06 lM which is less than half of
the value 10.78 lM observed for resveratrol, a common standard
used in murine tyrosinase activity studies [16].
A new library of coumarin thiazole derivatives has been
synthesised, characterised and evaluated for their a-glucosidase
inhibitory activity. The majority of the screened compounds
displayed potent inhibitory activities with IC50 values in the range
of 6.24–81.69 lM, when compared to the standard acarbose
(IC50 = 43.26 lM). Structure–activity relationship studies suggest
that the pattern of substitution in the phenyl ring is closely related
to the biological activity of this class of compound. Among all the
tested molecules, the most active compound is a non-competitive
inhibitor with a Ki of 6.86 lM [17].
Ursolic acid, abundant in the plant kingdom, is a well-known
compound with various promising biological activities including,
anti-cancer, anti-inﬂammatory, hepatoprotective, antiallergic
and anti-HIV properties. A library of ursolic acid-benzylidine
derivatives has recently been designed and synthesised using
Claisen Schmidt condensation of ursolic acid with various aromatic
aldehydes in an attempt to develop potent antitumour agents. The
compounds were evaluated against a panel of four human carci-
noma cell lines including, A-549 (lung), MCF-7 (breast), HCT-116
(colon), THP-1 (leukemia) and a normal human epithelial cell
line (FR-2). The results from MTT assay revealed that all the com-
pounds displayed high level of antitumour activities compared
with the previously reported triazole analogues [18].
A tetrahydropyran derivative has been discovered in a high-
throughput screening campaign to ﬁnd new inhibitors of mycobac-
terial InhA. Following initial in vitro proﬁling, a structure–activity
relationship study was initiated and a focussed library of analogues
was synthesised and evaluated. This yielded a new compound with
improved antimycobacterial activity and low cytotoxicity [19].
A series of novel arylpiperazine 5-(4-ﬂuorophenyl)-5-methyl-
hydantoins with 2-hydroxypropyl linker has been synthesised
and evaluated for afﬁnity towards the serotonin 5-HT7 receptor
(5-HT7R) in comparison with other closely related GPCRs. Func-
tional activity was studied through the measurement of 5-HT7R-
mediated cyclic AMP production in HEK293 cells stably expressing
human 5-HT7. The lead structure was also examined for prelimi-
nary metabolic stability using human liver microsomes. The pro-
cess of candidate selection for synthesis was supported by a
special molecular modeling workﬂow including combinatorial
library generation, docking, and machine learning-based assess-
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